Friday | August 6, 2021
LIFE SCIENCES BC ANNOUNCES ANNUAL AWARD WINNERS
Life Sciences BC is pleased to announce the recipients of the 23rd Annual Life Sciences BC Awards, presented by FARRIS. These awards recognize the talented individuals and organizations who contribute to the vibrant life sciences ecosystem in B.C. 
The 2021 Life Sciences BC Award Winners are:  
Company 
  • Life Sciences Company of the Year – AbCellera 
  • Medical/Digital Technology Company of the Year – Kardium 
  • Deal of the Year –Aurinia Pharmaceuticals Inc.
  • Strategic Life Sciences Partner of the Year – Novateur Ventures 
  • Emerging Life Sciences Company of the Year – Notch Therapeutics
  • Global Impact Award: Company – Acuitas Therapeutics 

Individual 
  • Milton Wong Award for Leadership – Northview Ventures: Doug Janzen  
  • Dr. Don Rix Award for Achievement in Life Sciences – Dr. Helen Burt 
  • Leadership Impact Award: Individual – Dr. Mel Krajden, BCCDC 

Research 
  • Genome BC Award for Scientific Excellence – Dr. Michael Russello 
  • Michael Smith Foundation for Health Research – Aubrey J. Tingle Prize – Dr. Ruth Grunau 
This year’s award winners exemplify leadership and innovative thinking; nurturing talent and drive the ongoing life sciences sector's success within British Columbia and beyond. Congratulations to all the winners and we look forward to seeing you at the awards in September!

Read the full press release of the announcement here
MEMBERSHIP BENEFITS
BioLinks in its usual format is taking a short break until Labour Day. Though the Life Sciences BC team continues to keep an eye on Member and Industry News, our team report switches to featuring our member benefits over the next few weeks. Along with workshops and other events, self-serve news and job postings, our members also have access to more than 30 discount offers, available on travel, lab supplies, office, and more.
With a month left of summer, utilize the travel discounts for any last-minute trips. LSBC offers over 16 different travel discounts listed below:
Advertising Opportunity with Business in Vancouver -- Our annual magazine, Life Sciences 2021, in production with Business in Vancouver, hits the stands in late September to coincide with our annual Awards ceremony. The deadline for an ad buy is August 11; further details and a media kit are available. 

Please contact Laura Torrance, Sales Manager with BIV on 604-608-5145 or ltorrance@biv.com. 

Platinum Sponsors
Our annual magazine, Life Sciences 2021, in production with Business in Vancouver, hits the stands in late September to coincide with our annual Awards ceremony. The deadline for an ad buy is August 11; further details and a media kit are available. 

Please contact Laura Torrance, Sales Manager with BIV on 604-608-5145 or ltorrance@biv.com. 

VANCOUVER, BC –Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that Janssen Biotech, Inc. (Janssen) dosed the first patient with JNJ-78278343, a bispecific antibody developed using Zymeworks’ Azymetric™ and EFECT™ therapeutic platforms. READ MORE
HOUSTON & VANCOUVER, BC –Tachyon Therapeutics, Inc., a research and development focused biotechnology company, and AbCellera a technology company with a centralized operating system for next-generation antibody discovery, announced a collaboration to facilitate the discovery and development of a therapeutic antibody targeting LEFTY1, a member of the transforming growth factor β (TGF-β) superfamily and validated extracellular drug target expressed in advanced cancers. 
VICTORIA, BC – IMMUNOPRECISE ANTIBODIES LTD., a leader in full-service, therapeutic antibody discovery and development, today announces the promotion of Dr. Barry Duplantis, Ph.D., to VP of Client Relations and welcomes Ms. Carla Dahl as VP of Marketing. 
EQRx, a company committed to developing and delivering important new medicines at radically lower prices, and AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, today announced a collaboration agreement for the discovery and development of therapeutic antibodies. READ MORE
Sixteen exceptional people will be appointed to the Order of British Columbia, the Province’s highest form of recognition, Lt. Gov. Janet Austin, chancellor of the order, has announced. This year, 257 British Columbians were nominated READ MORE
The federal government announced extensions of a number of pandemic economic support programs today, including the Canada Recovery Benefit (CRB) and the Canada Emergency Wage Subsidy (CEWS).
A news release from the Department of Finance says the eligibility period for CRB and CEWS has been extended to Oct. 23. The Canada Emergency Rent Subsidy (CERS), the Canada Recovery Caregiving Benefit (CRCB) and the Canada Recovery Sickness Benefit (CRSB) will also receive the same extension. READ MORE
Gold Sponsors
Utilizing a passionate and talented team, VoxCell is creating an extraordinary line of Truly Biomimetic solutions for the drug development industry and the field of Oncology research with vascularized cancer tissue models. Their 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D printed tissues. These models will increase confidence in new drug candidates, decrease the failure rate, and increase the speed for new therapies to get to the market.
The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada’s largest HIV/AIDS research, treatment and education facility, and is nationally and internationally recognized as an innovative world leader in combating HIV/AIDS and related diseases. The BC-CfE places diseases like HIV and viral hepatitis under the microscope and promotes evidence-based social policy to curb high-burden epidemics. The made-in-BC Treatment as Prevention® strategy (TasP® ) pioneered by Dr. Julio Montaner, inspired the ambitious global UNAIDS 90-90-90 Target to end AIDS as a global pandemic by 2030.
Silver Sponsors
PERSPECTIVES ON GLOBAL HEALTHCARE INNOVATION
What’s driving innovation in life science and healthcare? SVB is committed to serving the ecosystem by providing industry-leading reports featuring proprietary analysis and targeted outlooks to help companies and investors achieve their goals. Twice a year we publish deep-dive analyses describing fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank. To find out more about Silicon Valley Bank click here

Bronze Sponsors
Post A Job on the LSBC Website
LSBC Membership Discounts on Job Postings
 
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? CONTACT: Peter McLoughlin - talent@lifesciencesbc.ca